Awarded $14 Million Multi-Year NIH Grant and Initiated Second Clinical Trial for Breakthrough Therapy PF614-MPAR Submitted Pivotal PF614 Phase 3 ... or "switches off" the release of the opioid only in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback